Halotherapy relieves chronic obstructive pulmonary disease by alleviating NLRP3 inflammasome-mediated pyroptosis.

Zhang C, Zhu W, Meng Q, Lian N, Wu J, Liu B, Wang H, Wang X, Gu S, Wen J, Shen X, Li Y, Qi X

Open source

DOI
10.21037/atm-22-5632
Published
2022 Dec
Container
Annals of translational medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.21037/atm-22-5632,
  title = {Halotherapy relieves chronic obstructive pulmonary disease by alleviating NLRP3 inflammasome-mediated pyroptosis.},
  author = {Zhang C and Zhu W and Meng Q and Lian N and Wu J and Liu B and Wang H and Wang X and Gu S and Wen J and Shen X and Li Y and Qi X},
  year = {2022},
  journal = {Annals of translational medicine},
  doi = {10.21037/atm-22-5632},
  url = {https://doi.org/10.21037/atm-22-5632}
}

RIS

TY  - JOUR
TI  - Halotherapy relieves chronic obstructive pulmonary disease by alleviating NLRP3 inflammasome-mediated pyroptosis.
AU  - Zhang C
AU  - Zhu W
AU  - Meng Q
AU  - Lian N
AU  - Wu J
AU  - Liu B
AU  - Wang H
AU  - Wang X
AU  - Gu S
AU  - Wen J
AU  - Shen X
AU  - Li Y
AU  - Qi X
PY  - 2022
JO  - Annals of translational medicine
DO  - 10.21037/atm-22-5632
UR  - https://doi.org/10.21037/atm-22-5632
ER  - 

APA

C, Z., W, Z., Q, M., N, L., J, W., B, L., H, W., X, W., S, G., J, W., X, S., Y, L., & X, Q. (2022). Halotherapy relieves chronic obstructive pulmonary disease by alleviating NLRP3 inflammasome-mediated pyroptosis.. Annals of translational medicine. https://doi.org/10.21037/atm-22-5632

Source records